iTind

iTind is a leading medical equipment manufacturing company dedicated to improving men’s healthcare and quality of life through innovative, non-surgical solutions for Benign Prostatic Hyperplasia (BPH). iTind's flagship treatment for BPH holds the EU CE Mark and is approved for sale in the European Union, UK, Israel, Australia, Brazil, and is FDA cleared for use in the USA. The company’s commitment to innovation ensures that patients receive the most advanced and effective care possible.

The iTind treatment is a clinically-proven solution that alleviates lower urinary tract symptoms caused by an enlarged prostate. This groundbreaking procedure reshapes the anatomy of the prostatic urethra, gently creating a wider opening for urine to flow freely. Unlike traditional methods, iTind avoids burning or cutting out tissue and does not leave behind a permanent implant. This straightforward treatment does not require overnight hospitalization and minimizes side effects commonly associated with prescription medication. Clinical studies have demonstrated durable results for up to three years, making iTind a trusted choice for long-term relief.

iTind is located at 17 Hauman st., Hadera, IL. Designed with the active patient in mind, the passive 5 to 7-day treatment period minimizes downtime and preserves sexual function. iTind's approach offers rapid symptom relief in the majority of patients, with a temporary implant removed after the treatment period, and typically eliminates the need for a catheter. We invite the iTind management team to create a customized and exclusive company showcase and product listing on our platform to further highlight its innovative solutions and commitment to patient care.